BAUSCH HEALTH COS INC (BHC) Stock Analyst Ratings
USA - NYSE:BHC - CA0717341071 - Common Stock
7.03 USD
+0.01 (+0.14%)
ChartMill assigns a Buy % Consensus number of 49% to BHC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.32. This target is 4.19% above the current price.
BHC was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about BHC.
In the previous month the buy percentage consensus was at a similar level.
BHC was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-02 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-02-06 | Jefferies | Downgrade | Buy -> Hold |
| 2025-01-30 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-11-01 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-08-02 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-08-02 | Piper Sandler | Downgrade | Neutral -> Underweight |
| 2024-07-25 | Truist Securities | Maintains | Hold -> Hold |
| 2024-07-10 | Raymond James | Initiate | Market Perform |
| 2024-04-23 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-04-12 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-04-05 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2024-02-23 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-09-20 | Jefferies | Upgrade | Hold -> Buy |
| 2023-06-16 | TD Cowen | Downgrade | Outperform -> Market Perform |
| 2023-05-22 | Jefferies | Maintains | Buy -> Buy |
| 2023-05-05 | RBC Capital | Maintains | Sector Perform |
| 2022-09-09 | Piper Sandler | Maintains | Neutral |
| 2022-09-01 | RBC Capital | Maintains | Sector Perform |
| 2022-08-10 | BMO Capital | Maintains | Market Perform |
| 2022-08-10 | RBC Capital | Maintains | Sector Perform |
| 2022-07-29 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2022-07-29 | Truist Securities | Downgrade | Buy -> Hold |
| 2022-07-29 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2022-07-26 | RBC Capital | Maintains | Outperform |
| 2022-06-13 | JP Morgan | Reiterate | Overweight |
| 2022-05-13 | RBC Capital | Maintains | Outperform |
| 2022-05-09 | RBC Capital | Maintains | Outperform |
| 2021-11-03 | RBC Capital | Maintains | Outperform |
| 2021-05-05 | RBC Capital | Downgrade | Outperform |
| 2021-04-30 | RBC Capital | Maintains | Outperform |
BAUSCH HEALTH COS INC / BHC FAQ
What is the average price target for BAUSCH HEALTH COS INC (BHC) stock?
9 analysts have analysed BHC and the average price target is 7.32 USD. This implies a price increase of 4.19% is expected in the next year compared to the current price of 7.03.
What is the consensus rating for BHC stock?
The consensus rating for BAUSCH HEALTH COS INC (BHC) is 48.8889 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
Can you provide the analyst count for BAUSCH HEALTH COS INC stock?
The number of analysts covering BAUSCH HEALTH COS INC (BHC) is 9.